Cargando…
Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study
BACKGROUND: The World Health Organization has proposed that onchocerciasis elimination (interruption) of transmission be verified in 12 (approximately a third) endemic countries by 2030. The strategy to reach this goal is based on ivermectin Mass Drug Administration (MDA) with high geographical and...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655298/ https://www.ncbi.nlm.nih.gov/pubmed/37974087 http://dx.doi.org/10.1186/s12879-023-08806-8 |
_version_ | 1785147915561336832 |
---|---|
author | Otabil, Kenneth Bentum Basáñez, María-Gloria Ankrah, Blessing Bart-Plange, Emmanuel John Babae, Theophilus Nti Kudzordzi, Prince-Charles Darko, Vera Achiaa Raji, Abdul Sakibu Datsa, Lydia Boakye, Andrews Agyapong Yeboah, Michael Tawiah Fodjo, Joseph Nelson Siewe Schallig, Henk D. F. H. Colebunders, Robert |
author_facet | Otabil, Kenneth Bentum Basáñez, María-Gloria Ankrah, Blessing Bart-Plange, Emmanuel John Babae, Theophilus Nti Kudzordzi, Prince-Charles Darko, Vera Achiaa Raji, Abdul Sakibu Datsa, Lydia Boakye, Andrews Agyapong Yeboah, Michael Tawiah Fodjo, Joseph Nelson Siewe Schallig, Henk D. F. H. Colebunders, Robert |
author_sort | Otabil, Kenneth Bentum |
collection | PubMed |
description | BACKGROUND: The World Health Organization has proposed that onchocerciasis elimination (interruption) of transmission be verified in 12 (approximately a third) endemic countries by 2030. The strategy to reach this goal is based on ivermectin Mass Drug Administration (MDA) with high geographical and therapeutic coverage. In addition to coverage, high levels of treatment adherence are paramount. We investigated factors associated with ivermectin intake in an area of Ghana with persistent Onchocerca volvulus infection. METHODS: In August 2021, a cross-sectional mixed-methods study was conducted in 13 onchocerciasis-endemic communities in the Bono Region of Ghana. Individuals aged ≥ 10 years were invited to participate in a questionnaire survey. A total of 48 focus group discussions and in-depth interviews with 10 community drug distributors and 13 community leaders were conducted. RESULTS: A total of 510 people participated in the study [median age: 32, interquartile range 30 (20‒50) years]; 274 (53.7%) were females. Of the total, 320 (62.7%) declared that they adhered to each treatment round and 190 (37.3%) admitted they had not taken ivermectin during at least one MDA round, since becoming eligible for treatment. Of 483 participants with complete information, 139 (28.8%) did not take ivermectin during the last round (March 2021), and 24 (5.0%) had never taken ivermectin (systematic non-adherers). Reasons for not taking ivermectin included previous experience/fear of side-effects, being absent during MDA, pregnancy, the desire to drink alcohol, and drug distribution challenges. Being male, having good knowledge and perception of the disease, and not having secondary or higher level of formal education were significantly associated with higher odds of ivermectin intake. CONCLUSIONS: A relatively high level of non-adherence to ivermectin treatment was documented. There is a need for targeted educational and behavioural change campaigns to reverse these trends and ensure a steady course toward meeting onchocerciasis elimination targets in Ghana. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-023-08806-8. |
format | Online Article Text |
id | pubmed-10655298 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-106552982023-11-16 Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study Otabil, Kenneth Bentum Basáñez, María-Gloria Ankrah, Blessing Bart-Plange, Emmanuel John Babae, Theophilus Nti Kudzordzi, Prince-Charles Darko, Vera Achiaa Raji, Abdul Sakibu Datsa, Lydia Boakye, Andrews Agyapong Yeboah, Michael Tawiah Fodjo, Joseph Nelson Siewe Schallig, Henk D. F. H. Colebunders, Robert BMC Infect Dis Research BACKGROUND: The World Health Organization has proposed that onchocerciasis elimination (interruption) of transmission be verified in 12 (approximately a third) endemic countries by 2030. The strategy to reach this goal is based on ivermectin Mass Drug Administration (MDA) with high geographical and therapeutic coverage. In addition to coverage, high levels of treatment adherence are paramount. We investigated factors associated with ivermectin intake in an area of Ghana with persistent Onchocerca volvulus infection. METHODS: In August 2021, a cross-sectional mixed-methods study was conducted in 13 onchocerciasis-endemic communities in the Bono Region of Ghana. Individuals aged ≥ 10 years were invited to participate in a questionnaire survey. A total of 48 focus group discussions and in-depth interviews with 10 community drug distributors and 13 community leaders were conducted. RESULTS: A total of 510 people participated in the study [median age: 32, interquartile range 30 (20‒50) years]; 274 (53.7%) were females. Of the total, 320 (62.7%) declared that they adhered to each treatment round and 190 (37.3%) admitted they had not taken ivermectin during at least one MDA round, since becoming eligible for treatment. Of 483 participants with complete information, 139 (28.8%) did not take ivermectin during the last round (March 2021), and 24 (5.0%) had never taken ivermectin (systematic non-adherers). Reasons for not taking ivermectin included previous experience/fear of side-effects, being absent during MDA, pregnancy, the desire to drink alcohol, and drug distribution challenges. Being male, having good knowledge and perception of the disease, and not having secondary or higher level of formal education were significantly associated with higher odds of ivermectin intake. CONCLUSIONS: A relatively high level of non-adherence to ivermectin treatment was documented. There is a need for targeted educational and behavioural change campaigns to reverse these trends and ensure a steady course toward meeting onchocerciasis elimination targets in Ghana. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-023-08806-8. BioMed Central 2023-11-16 /pmc/articles/PMC10655298/ /pubmed/37974087 http://dx.doi.org/10.1186/s12879-023-08806-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Otabil, Kenneth Bentum Basáñez, María-Gloria Ankrah, Blessing Bart-Plange, Emmanuel John Babae, Theophilus Nti Kudzordzi, Prince-Charles Darko, Vera Achiaa Raji, Abdul Sakibu Datsa, Lydia Boakye, Andrews Agyapong Yeboah, Michael Tawiah Fodjo, Joseph Nelson Siewe Schallig, Henk D. F. H. Colebunders, Robert Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study |
title | Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study |
title_full | Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study |
title_fullStr | Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study |
title_full_unstemmed | Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study |
title_short | Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study |
title_sort | non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the bono region of ghana: a mixed-methods study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655298/ https://www.ncbi.nlm.nih.gov/pubmed/37974087 http://dx.doi.org/10.1186/s12879-023-08806-8 |
work_keys_str_mv | AT otabilkennethbentum nonadherencetoivermectininonchocerciasisendemiccommunitieswithpersistentinfectioninthebonoregionofghanaamixedmethodsstudy AT basanezmariagloria nonadherencetoivermectininonchocerciasisendemiccommunitieswithpersistentinfectioninthebonoregionofghanaamixedmethodsstudy AT ankrahblessing nonadherencetoivermectininonchocerciasisendemiccommunitieswithpersistentinfectioninthebonoregionofghanaamixedmethodsstudy AT bartplangeemmanueljohn nonadherencetoivermectininonchocerciasisendemiccommunitieswithpersistentinfectioninthebonoregionofghanaamixedmethodsstudy AT babaetheophilusnti nonadherencetoivermectininonchocerciasisendemiccommunitieswithpersistentinfectioninthebonoregionofghanaamixedmethodsstudy AT kudzordziprincecharles nonadherencetoivermectininonchocerciasisendemiccommunitieswithpersistentinfectioninthebonoregionofghanaamixedmethodsstudy AT darkoveraachiaa nonadherencetoivermectininonchocerciasisendemiccommunitieswithpersistentinfectioninthebonoregionofghanaamixedmethodsstudy AT rajiabdulsakibu nonadherencetoivermectininonchocerciasisendemiccommunitieswithpersistentinfectioninthebonoregionofghanaamixedmethodsstudy AT datsalydia nonadherencetoivermectininonchocerciasisendemiccommunitieswithpersistentinfectioninthebonoregionofghanaamixedmethodsstudy AT boakyeandrewsagyapong nonadherencetoivermectininonchocerciasisendemiccommunitieswithpersistentinfectioninthebonoregionofghanaamixedmethodsstudy AT yeboahmichaeltawiah nonadherencetoivermectininonchocerciasisendemiccommunitieswithpersistentinfectioninthebonoregionofghanaamixedmethodsstudy AT fodjojosephnelsonsiewe nonadherencetoivermectininonchocerciasisendemiccommunitieswithpersistentinfectioninthebonoregionofghanaamixedmethodsstudy AT schallighenkdfh nonadherencetoivermectininonchocerciasisendemiccommunitieswithpersistentinfectioninthebonoregionofghanaamixedmethodsstudy AT colebundersrobert nonadherencetoivermectininonchocerciasisendemiccommunitieswithpersistentinfectioninthebonoregionofghanaamixedmethodsstudy |